Predicting when migraine attacks will occur
Forecasting Migraine Attacks
['FUNDING_R01'] · MASSACHUSETTS GENERAL HOSPITAL · NIH-11031334
This study is working on a new tool called HAPRED-III that helps people with migraines predict when they might have an attack by looking at things like their sleep, mood, and medication use, so they can take action early and hopefully lessen the pain.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MASSACHUSETTS GENERAL HOSPITAL (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-11031334 on ClinicalTrials.gov |
What this research studies
This research aims to improve the prediction of migraine attacks by developing a new forecasting model called HAPRED-III. By incorporating various factors such as sleep, mood, medication use, and early symptoms, the model seeks to provide individuals with a better understanding of their daily risk for experiencing a migraine. This proactive approach allows patients to utilize abortive medications more effectively and potentially reduce the severity of their attacks. The model will continuously update its predictions using advanced statistical methods, enhancing its accuracy over time.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who experience frequent migraines and are looking for better ways to manage their condition.
Not a fit: Patients who do not suffer from migraines or have infrequent migraine episodes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could help patients manage their migraines more effectively by predicting attacks and allowing for timely intervention.
How similar studies have performed: Previous models for migraine prediction have shown promise, but this new approach aims to address their limitations and enhance predictive accuracy.
Where this research is happening
BOSTON, UNITED STATES
- MASSACHUSETTS GENERAL HOSPITAL — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HOULE, TIMOTHY T — MASSACHUSETTS GENERAL HOSPITAL
- Study coordinator: HOULE, TIMOTHY T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.